Stay updated on Apalutamide Study in High-Risk Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Apalutamide Study in High-Risk Prostate Cancer Clinical Trial page.

Latest updates to the Apalutamide Study in High-Risk Prostate Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 is now displayed; the notice about a lapse in government funding and the earlier Revision: v3.4.1 have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check21 days agoChange DetectedAdded a government funding/status notice and updated the system revision from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check28 days agoChange DetectedUI enhancements were added to the history view, including a Show glossary option and a legend for color-coded additions (green) and deletions (red). Minor wording changes for No FEAR Act data and an updated Revision: v3.4.0 were also applied.SummaryDifference0.4%

- Check35 days agoChange DetectedLatest version history adds Contacts/Locations and Study Status entries (dated 2026-01-16 and 2026-01-15). It also removes the 2025-12-05 version from the history.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision: v3.3.4 added and Revision: v3.3.3 removed in the page history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check64 days agoChange DetectedFooter now shows Revision: v3.3.3, and the HHS Vulnerability Disclosure text/link and the Revision: v3.3.2 entry were removed.SummaryDifference0.1%

Stay in the know with updates to Apalutamide Study in High-Risk Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Apalutamide Study in High-Risk Prostate Cancer Clinical Trial page.